WuXi Biologics to Build Biomanufacturing Facility in Ireland

Published: May 02, 2018

Wuxi Biologics is to invest $392 million to build a new biologics drug substance manufacturing facility in Ireland. The new facility will use single-use bioreactors for commercial biomanufacturing. This is also WuXi Biologics’ first manufacturing site outside of China. A total of 48,000 L fed-batch and 6,000 L perfusion bioreactor capacity will be installed. This facility will create approximately 700 jobs during its construction and over 400 highly skilled jobs after establishment over 5 years. More details....

Back to news